文献速递糖尿病肥胖与代谢综合征

二甲双胍与运动训练对餐后血糖及葡萄糖动力学的交互作用:随机临床试验

The interaction between metformin and physical activity on postprandial glucose and glucose kinetics: a randomised, clinical trial.
PubMed 文献 · Diabetologia · 2020-09-26

这项平行组、双盲随机临床试验在糖耐量受损的超重/肥胖个体中评估二甲双胍与运动训练的交互作用。受试者随机接受安慰剂(n=15)或二甲双胍(n=14),经历基线、用药3周后和训练12周后三个实验日。结果显示两组餐后血糖从基线到训练后均改善(各降0.7 mmol/l),组间无差异(p=0.92);但血糖下降的时间进程不同,提示两种干预存在交互作用。

要点

  • 二甲双胍联合运动训练在改善餐后血糖方面并不优于单用运动训练。
  • 两组餐后血糖从基线到训练后均下降0.7 mmol/l,组间差异无统计学意义。
  • 混合餐耐量试验中血糖下降的时间点不同,提示二甲双胍与运动存在交互作用。

核心结论

  • 二甲双胍联合运动训练在改善餐后血糖方面不优于单用运动训练。
  • 混合餐耐量试验中血糖下降的时间效应不同,提示两种干预方式存在交互作用。

研究设计与样本

  • 平行组、双盲(研究者和受试者均盲)随机临床试验,纳入糖耐量受损且超重/肥胖(BMI 25-42 kg/m2)个体。
  • 随机分配至安慰剂组(PLA,n=15)或二甲双胍组(MET,n=14),进行三个实验日:基线、用药后(二甲双胍2 g/天或安慰剂3周)和训练后(联合运动训练12周)。
  • 运动训练为监督下的自行车间歇训练,平均强度为64% Wattmax,每次45分钟,每周4次。
  • 主要结局为混合餐耐量试验(MMTT)期间餐后平均血糖浓度。
  • 统计方法:组内差异采用双因素重复测量ANOVA评估组×时间交互作用,组间变化采用非配对双尾Student t检验。

主要发现

  • 餐后血糖从基线到训练后在PLA组和MET组均改善(ΔPLA:-0.7 [95%CI -1.4, 0.0] mmol/l,p=0.05;ΔMET:-0.7 [-1.5, -0.0] mmol/l,p=0.03),组间无差异(p=0.92)。
  • PLA组从用药后到训练后观察到全部血糖下降(-0.8 [-1.3, -0.1] mmol/l,p=0.01)。
  • MET组从基线到用药后观察到全部血糖下降(-0.9 [-1.6, -0.2] mmol/l,p=0.01)。
  • MMTT平均血糖从基线到训练后的下降依赖不同时间效应:PLA组在t=120 min观察到下降(p=0.009),MET组在t=30 min观察到下降(p<0.001)。
  • V̇O2peak从用药后到训练后增加15%(4.6 [3.3, 5.9] ml kg-1 min-1,p<0.0001),体重从基线到训练后下降(-4.0 [-5.2, -2.7] kg,p<0.0001),组间无差异(p分别为0.7和0.5)。

关键数值与推荐

  • 糖耐量受损定义:2小时OGTT血糖7.8-11.0 mmol/l和/或HbA1c 39-47 mmol/mol(5.7-6.5%),或未使用降糖药的2型糖尿病。
  • 超重/肥胖定义:BMI 25-42 kg/m2。
  • 二甲双胍剂量:2 g/天,持续3周。
  • 运动训练方案:监督下自行车间歇训练,平均强度64% Wattmax,45分钟/次,4次/周,共12周。

临床怎么用

  • 对于糖耐量受损的超重/肥胖个体,运动训练可改善餐后血糖,加用二甲双胍未显示额外优于运动训练的获益。
  • 二甲双胍与运动训练对餐后血糖的作用时间点不同,临床评估或联合干预设计时需考虑此交互特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The aim of this parallel-group, double-blinded (study personnel and participants), randomised clinical trial was to assess the interaction between metformin and exercise training on postprandial glucose in glucose-intolerant individuals. METHODS: Glucose-intolerant (2 h OGTT glucose of 7.8-11.0 mmol/l and/or HbA1c of 39-47 mmol/mol [5.7-6.5%] or glucose-lowering-medication naive type 2 diabetes), overweight/obese (BMI 25-42 kg/m2) individuals were randomly allocated to a placebo study group (PLA, n = 15) or a metformin study group (MET, n = 14), and underwent 3 experimental days: BASELINE (before randomisation), MEDICATION (after 3 weeks of metformin [2 g/day] or placebo treatment) and TRAINING (after 12 weeks of exercise training in combination with metformin/placebo treatment). Training consisted of supervised bicycle interval sessions with a mean intensity of 64% of Wattmax for 45 min, 4 times/week. The primary outcome was postprandial glucose (mean glucose concentration) during a mixed meal tolerance test (MMTT), which was assessed on each experimental day. For within-group differences, a group × time interaction was assessed using two-way repeated measures ANOVA. Between-group changes of the outcomes at different timepoints were compared using unpaired two-tailed Student's t tests. RESULTS: Postprandial glucose improved from BASELINE to TRAINING in both the PLA group and the MET group (∆PLA: -0.7 [95% CI -1.4, 0.0] mmol/l, p = 0.05 and ∆MET: -0.7 [-1.5, -0.0] mmol/l, p = 0.03), with no between-group difference (p = 0.92). In PLA, the entire reduction was seen from MEDICATION to TRAINING (-0.8 [-1.3, -0.1] mmol/l, p = 0.01). Conversely, in MET, the entire reduction was observed from BASELINE to MEDICATION (-0.9 [-1.6, -0.2] mmol/l, p = 0.01). The reductions in mean glucose concentration during the MMTT from BASELINE to TRAINING were dependent on differential time effects: in the PLA group, a decrease was observed at timepoint (t) = 120 min (p = 0.009), whereas in the MET group, a reduction occurred at t = 30 min (p < 0.001). V̇O2peak increased 15% (4.6 [3.3, 5.9] ml kg-1 min-1, p < 0.0001) from MEDICATION to TRAINING and body weight decreased (-4.0 [-5.2, -2.7] kg, p < 0.0001) from BASELINE to TRAINING, with no between-group differences (p = 0.7 and p = 0.5, respectively). CONCLUSIONS/INTERPRETATION: Metformin plus exercise training was not superior to exercise training alone in improving postprandial glucose. The differential time effects during the MMTT suggest an interaction between the two modalities. FUNDING: The Beckett foundation, A.P Møller Foundation, DDA, the Research Foundation of Rigshospitalet and Trygfonden. TRIAL REGISTRATION: ClinicalTrials.gov (NCT03316690). Graphical abstract.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Pilmark NS, Lyngbæk M, Oberholzer L, et al. The interaction between metformin and physical activity on postprandial glucose and glucose kinetics: a randomised, clinical trial. Diabetologia. 2020. PMID: 32979074. doi:10.1007/s00125-020-05282-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。